<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Aminophylline: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int735-aminophylline.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="bnf_int735-aminophylline.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int735-aminophylline.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a> &gt; <a href="bnf_int734-theophylline.htm">Theophylline</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int734-theophylline.htm" title="Previous: Theophylline">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int935-thyroid-hormones.htm" title="Next: Thyroid Hormones">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Aminophylline</h1><?highlighter on?><div id="pC" class="jN"><p><strong>Aminophylline</strong> has no specific interaction information.</p><p><strong>Aminophylline</strong> belongs to <strong>Theophylline</strong> and will have the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int551-acetazolamide.htm">Acetazolamide</a></td><td><p><span>increased risk of hypokalaemia when </span> <span>theophylline</span> <span>given with</span> <span>acetazolamide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int392-aciclovir.htm">Aciclovir</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>aciclovir</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to topical aciclovir preparations</p></div></td></tr><tr><td><a href="bnf_int117-adenosine.htm">Adenosine</a></td><td><p><span></span> <span>theophylline</span> <span>antagonises anti-arrhythmic effect of</span> <span>adenosine</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Possibility of interaction with drugs tending to impair myocardial conduction</p></div></td></tr><tr><td><a href="bnf_int22-allopurinol.htm">Allopurinol</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>allopurinol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int405-benzodiazepines.htm">Benzodiazepines</a></td><td><p><span></span> <span>theophylline</span> <span>possibly reduces effects of</span> <span>benzodiazepines</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int466-calcium-channel-blockers.htm">Calcium-channel Blockers</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>calcium-channel blockers</span> <span>(enhanced effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Dihydropyridine calcium-channel blockers include amlodipine, felodipine, isradipine, lacidipine, lercanidipine, nicardipine, nifedipine, and nimodipine</p></div></td></tr><tr><td><a href="bnf_int277-carbamazepine.htm">Carbamazepine</a></td><td><p><span>metabolism of </span> <span>theophylline</span> <span>accelerated by</span> <span>carbamazepine</span> <span>(reduced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int744-cimetidine.htm">Cimetidine</a></td><td class="cAI"><p><span>metabolism of </span> <span>theophylline</span> <span>inhibited by</span> <span>cimetidine</span> <span>(increased plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int195-ciprofloxacin.htm">Ciprofloxacin</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>ciprofloxacin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int168-clarithromycin.htm">Clarithromycin</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>clarithromycin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int484-corticosteroids.htm">Corticosteroids</a></td><td><p><span>increased risk of hypokalaemia when </span> <span>theophylline</span> <span>given with</span> <span>corticosteroids</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</p></div></td></tr><tr><td><a href="bnf_int1072-deferasirox.htm">Deferasirox</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>deferasirox</span> <span>(consider reducing dose of <span>theophylline</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int468-diltiazem.htm">Diltiazem</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>diltiazem</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int523-disulfiram.htm">Disulfiram</a></td><td><p><span>metabolism of </span> <span>theophylline</span> <span>inhibited by</span> <span>disulfiram</span> <span>(increased risk of toxicity)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int539-diuretics-loop.htm">Diuretics, Loop</a></td><td><p><span>increased risk of hypokalaemia when </span> <span>theophylline</span> <span>given with</span> <span>loop diuretics</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int525-diuretics-thiazide-and-related.htm">Diuretics, Thiazide and related</a></td><td><p><span>increased risk of hypokalaemia when </span> <span>theophylline</span> <span>given with</span> <span>thiazides and related diuretics</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int561-doxapram.htm">Doxapram</a></td><td><p><span>increased CNS stimulation when </span> <span>theophylline</span> <span>given with</span> <span>doxapram</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int708-ephedrine.htm">Ephedrine</a></td><td><p><span>manufacturer of </span> <span>theophylline</span> <span>advises avoid concomitant use with</span> <span>ephedrine</span> <span>in children</span>  </p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>erythromycin</span> <span>(also <span>theophylline</span> may reduce absorption of oral<span>erythromycin</span>)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int1178-febuxostat.htm">Febuxostat</a></td><td class="cAI"><p><span>caution with </span> <span>theophylline</span> <span>advised by manufacturer of</span> <span>febuxostat</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int301-fluconazole.htm">Fluconazole</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>fluconazole</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> In general, fluconazole interactions relate to multiple-dose treatment</p></div></td></tr><tr><td><a href="bnf_int235-fluvoxamine.htm">Fluvoxamine</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>fluvoxamine</span> <span>(concomitant use should usually be avoided, but where not possible halve <span>theophylline</span> dose and monitor plasma-<span>theophylline</span> concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1100-halothane.htm">Halothane</a></td><td><p><span>increased risk of arrhythmias when </span> <span>theophylline</span> <span>given with</span> <span>halothane</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int758-influenza-vaccine.htm">Influenza Vaccine</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>influenza vaccine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int586-interferon-alfa.htm">Interferon Alfa</a></td><td class="cAI"><p><span>metabolism of </span> <span>theophylline</span> <span>inhibited by</span> <span>interferon alfa</span> <span>(consider reducing dose of <span>theophylline</span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int165-isoniazid.htm">Isoniazid</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>isoniazid</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int45-ketamine.htm">Ketamine</a></td><td><p><span>increased risk of convulsions when </span> <span>theophylline</span> <span>given with</span> <span>ketamine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>ketoconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int372-lithium.htm">Lithium</a></td><td><p><span></span> <span>theophylline</span> <span>increases excretion of</span> <span>lithium</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int511-methotrexate.htm">Methotrexate</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>methotrexate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int197-norfloxacin.htm">Norfloxacin</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>norfloxacin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int636-oestrogens.htm">Oestrogens</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>oestrogens</span> <span>(consider reducing dose of <span>theophylline</span>)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a></p></div></td></tr><tr><td><a href="bnf_int826-pentoxifylline.htm">Pentoxifylline</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>pentoxifylline</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int437-phenobarbital.htm">Phenobarbital</a></td><td class="cAI"><p><span>metabolism of </span> <span>theophylline</span> <span>accelerated by</span> <span>phenobarbital</span> <span>(reduced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td class="cAI"><p><span>plasma concentration of both drugs reduced when </span> <span>theophylline</span> <span>given with</span> <span>phenytoin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int125-propafenone.htm">Propafenone</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>propafenone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int193-quinolones.htm">Quinolones</a></td><td class="cAI"><p><span>possible increased risk of convulsions when </span> <span>theophylline</span> <span>given with</span> <span>quinolones</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int201-rifampicin.htm">Rifampicin</a></td><td><p><span>metabolism of </span> <span>theophylline</span> <span>accelerated by</span> <span>rifampicin</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td class="cAI"><p><span>metabolism of </span> <span>theophylline</span> <span>accelerated by</span> <span>ritonavir</span> <span>(reduced plasma concentration)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1190-roflumilast.htm">Roflumilast</a></td><td><p><span>avoidance of </span> <span>theophylline</span> <span>advised by manufacturer of</span> <span>roflumilast</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int905-st-johns-wort.htm">St John's Wort</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>reduced by</span> <span>St John's wort</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int755-sucralfate.htm">Sucralfate</a></td><td><p><span>absorption of  </span> <span>theophylline</span> <span>possibly reduced by</span> <span>sucralfate</span> <span>(give at least 2 hours apart)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int689-sulfinpyrazone.htm">Sulfinpyrazone</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>reduced by</span> <span>sulfinpyrazone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int720-sympathomimetics-beta-2.htm">Sympathomimetics, Beta<sub>2</sub></a></td><td><p><span>increased risk of hypokalaemia when </span> <span>theophylline</span> <span>given with high doses of</span> <span>beta<sub>2</sub> sympathomimetics</span> <span>—see Hypokalaemia, <a title="CSM hypokalaemia (target-block)" href="PHP1734-selective-beta-2-agonists.htm#PHP1741">section 3.1.1.1</a></span>  </p></td><td></td></tr><tr><td><a href="bnf_int467-verapamil.htm">Verapamil</a></td><td class="cAI"><p><span>plasma concentration of </span> <span>theophylline</span> <span>increased by</span> <span>verapamil</span> <span>(enhanced effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int859-zafirlukast.htm">Zafirlukast</a></td><td><p><span>plasma concentration of </span> <span>theophylline</span> <span>possibly increased by</span> <span>zafirlukast</span> <span>, also plasma concentration of <span>zafirlukast</span> reduced</span>  </p></td><td></td></tr></tbody></table></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int734-theophylline.htm">Previous: Theophylline</a> | <a class="top" href="bnf_int735-aminophylline.htm#">Top</a> | <a accesskey="]" href="bnf_int935-thyroid-hormones.htm">Next: Thyroid Hormones</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>